Medpace Holdings Inc diskutieren
Medpace Holdings Inc
WKN: A2APTV / Symbol: MEDP / Name: Medpace Holdings / Aktie / Biotechnologie & medizinische Forschung / Mid Cap /
350,40 €
4,16 %
Medpace Holdings, Inc. (NASDAQ: MEDP) had its price target lowered by analysts at TD Cowen from $413.00 to $372.00. They now have a "buy" rating on the stock.
Ratings data for MEDP provided by MarketBeat
Medpace Holdings, Inc. (NASDAQ: MEDP) had its price target lowered by analysts at Mizuho from $400.00 to $355.00. They now have an "outperform" rating on the stock.
Ratings data for MEDP provided by MarketBeat
Medpace Holdings, Inc. (NASDAQ: MEDP) had its "sell" rating re-affirmed by analysts at TD Cowen. They now have a $366.00 price target on the stock, up previously from $283.00.
Ratings data for MEDP provided by MarketBeat
Medpace Holdings, Inc. (NASDAQ: MEDP) was downgraded by analysts at Cowen Inc from a "buy" rating to a "sell" rating.
Ratings data for MEDP provided by MarketBeat
Medpace Holdings, Inc. (NASDAQ: MEDP) had its price target raised by analysts at Mizuho from $328.00 to $510.00. They now have an "outperform" rating on the stock.
Ratings data for MEDP provided by MarketBeat
Medpace Holdings, Inc. (NASDAQ: MEDP) was downgraded by analysts at UBS Group AG from a "neutral" rating to a "sell" rating. They now have a $305.00 price target on the stock.
Ratings data for MEDP provided by MarketBeat
Medpace (NASDAQ:MEDP) had its price target raised by analysts at Mizuho from $575.00 to $655.00. They now have an "outperform" rating on the stock.
Ratings data for MEDP provided by MarketBeat
Medpace (NASDAQ:MEDP) had its "sell" rating reaffirmed by analysts at Cowen Inc.
Ratings data for MEDP provided by MarketBeat
Medpace (NASDAQ:MEDP) had its price target raised by analysts at TD Cowen from $356.00 to $462.00. They now have a "sell" rating on the stock.
Ratings data for MEDP provided by MarketBeat
Medpace (NASDAQ:MEDP) was upgraded by analysts at Robert W. Baird from a "neutral" rating to an "outperform" rating. They now have a $564.00 price target on the stock.
Ratings data for MEDP provided by MarketBeat
Medpace (MEDP) is now covered by Royal Bank Of Canada. They set an "outperform" rating and a $522.00 price target on the stock.
Ratings data for MEDP provided by MarketBeat
Medpace (MEDP) had its price target lowered by Robert W. Baird from $565.00 to $477.00. They now have an "outperform" rating on the stock.
Ratings data for MEDP provided by MarketBeat
Medpace (MEDP) had its "outperform" rating reaffirmed by Royal Bank Of Canada.
Ratings data for MEDP provided by MarketBeat
Neueste Beiträge
The_Goldman_Sachs_Gr in Biogen Inc. diskutieren